Home/Filings/4/0001628280-25-049954
4//SEC Filing

ACKERMAN JOEL 4

Accession 0001628280-25-049954

CIK 0000771856other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 11:19 AM ET

Size

7.0 KB

Accession

0001628280-25-049954

Insider Transaction Report

Form 4
Period: 2025-10-30
ACKERMAN JOEL
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Option to purchase Common Stock

    2025-10-30$2.10/sh94,405$198,2510 total
    Exercise: $2.10Exp: 2025-11-01Common Stock (94,405 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-30$2.10/sh+94,405$198,2511,056,539 total
Footnotes (1)
  • [F1]70,804 options were immediately exercisable on grant date of July 19, 2016, with the remaining options vesting and available to exercise on October 31, 2016.

Issuer

CHAMPIONS ONCOLOGY, INC.

CIK 0000771856

Entity typeother

Related Parties

1
  • filerCIK 0001220630

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 11:19 AM ET
Size
7.0 KB